The financial media habitually root for market milestones such as Dow 27,000, but that’s not where you should focus as an investor. Read More
John Persinos is the editorial director of Investing Daily, overseeing such publications as Personal Finance, Utility Forecaster, Profit Catalyst Alert, Rapier's Income Accelerator, Income Forecaster, and Marijuana Investing Daily, among others. John also writes the Mind Over Markets daily stock market recap, and he's the chief investment strategist of Marijuana Profit Alert.
John has decades of experience in the technology and political realms. He has worked as a staff editor at Inc. and Venture magazines, and written for Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, to name a few. In a career that has spanned more than 40 years, John has been diligently and prolifically covering the news and its impact on investors.
John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan (D-ND). John started his career as a daily newspaperman with The Orlando Sentinel.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
Here’s a look at the latest earnings and economic numbers and the risks they reveal right now for investors. Read More
In our mailbag segment this week, we address tariffs, financial scams, water utilities, Social Security, and shrinking human attention spans. Read More
Second-quarter earnings season kicked into high gear this week with results from the big banks. The sector’s profits are accelerating. Read More
Negative economic reports this week from China cast doubt on the resiliency of the country's growth and by extension, the health of the global economy. Read More
Economic growth and Federal Reserve dovishness are propelling the stock market to record highs. Are investors too complacent? Read More
The market seems to be on the precipice of a correction, or worse. We asked one of our top experts for bear-beating advice. Read More
This small marijuana biotech has garnered intense investor interest, with sharp swings up and down. What’s the real story behind CBIS? Read More
E-commerce giant Amazon dominates the retail jungle, but do competitors and bearish economic indicators threaten the stock? Read More
American Green is a marijuana penny stock in the news lately. Is this company poised for explosive growth or will it crash and burn? Read More